AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
EXPRESSION AND FUNCTION OF THE MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR-RECEPTOR IN ACUTE MYELOID-LEUKEMIA BLASTS
Authors: WETZLER M BERNSTEIN SH BAUMANN H FRIES KM STEWART C BLUMENSON L BAER MR HERZIG GP BLOOMFIELD CD SLACK JL
Citation: M. Wetzler et al., EXPRESSION AND FUNCTION OF THE MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR-RECEPTOR IN ACUTE MYELOID-LEUKEMIA BLASTS, Leukemia & lymphoma, 30(5-6), 1998, pp. 415
SEVERE CEREBELLAR SWELLING AND THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH FK506
Authors: TEZCAN H ZIMMER W FENSTERMAKER R HERZIG GP SCHRIBER J
Citation: H. Tezcan et al., SEVERE CEREBELLAR SWELLING AND THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH FK506, Bone marrow transplantation, 21(1), 1998, pp. 105-109
DELPHI-PANEL ANALYSIS OF APPROPRIATENESS OF HIGH-DOSE THERAPY AND BONE-MARROW TRANSPLANTS IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION
Authors: GALE RP PARK RE DUBOIS RW HERZIG GP HOCKING WG HOROWITZ MM KEATING A KEMPIN S LINKER CA SCHIFFER CA WIERNIK PH WEISDORF DJ RAI KR
Citation: Rp. Gale et al., DELPHI-PANEL ANALYSIS OF APPROPRIATENESS OF HIGH-DOSE THERAPY AND BONE-MARROW TRANSPLANTS IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION, Leukemia research, 22(11), 1998, pp. 973-981
REARRANGEMENT OF ALL1 (MLL) IN ACUTE MYELOID-LEUKEMIA WITH NORMAL CYTOGENETICS
Authors: CALIGIURI MA STROUT MP LAWRENCE D ARTHUR DC BAER MR YU F KNUUTILA S MROZEK K OBERKIRCHER AR MARCUCCI G DELACHAPELLE A ELONEN E BLOCK AW RAO PN HERZIG GP POWELL BL RUUTU T SCHIFFER CA BLOOMFIELD CD
Citation: Ma. Caligiuri et al., REARRANGEMENT OF ALL1 (MLL) IN ACUTE MYELOID-LEUKEMIA WITH NORMAL CYTOGENETICS, Cancer research, 58(1), 1998, pp. 55-59
INTERFERON-ALPHA-ASSOCIATED FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH MASSIVE PROTEINURIA IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA FOLLOWINGHIGH-DOSE CHEMOTHERAPY
Authors: SHAH M JENIS EH MOOKERJEE BK SCHRIBER JR BAER MR HERZIG GP WETZLER M
Citation: M. Shah et al., INTERFERON-ALPHA-ASSOCIATED FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH MASSIVE PROTEINURIA IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA FOLLOWINGHIGH-DOSE CHEMOTHERAPY, Cancer, 83(9), 1998, pp. 1938-1946
A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: BERNSTEIN SH NADEMANEE AP VOSE JM TRICOT G FAY JW NEGRIN RS DIPERSIO J RONDON G CHAMPLIN R BARNETT MJ CORNETTA K HERZIG GP VAUGHAN W GEILS G KEATING J MESSNER H WOLFF SN MILLER KB LINKER C CAIRO M HELLMANN S ASHBY M STRYKER S NASH RA
Citation: Sh. Bernstein et al., A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 91(9), 1998, pp. 3509-3517
SEQUENTIAL INTERLEUKIN-3 AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIOR TO AND FOLLOWING HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE - A PHASE I II TRIAL/
Authors: BERNSTEIN SH FAY JP CHRISTIANSEN NP PINERO L SHAH D STEPHAN M HERZIG GP
Citation: Sh. Bernstein et al., SEQUENTIAL INTERLEUKIN-3 AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIOR TO AND FOLLOWING HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE - A PHASE I II TRIAL/, Clinical cancer research, 3(9), 1997, pp. 1519-1526
EXPRESSION OF C-MPL MESSENGER-RNA, THE RECEPTOR FOR THROMBOPOIETIN, IN ACUTE MYELOID-LEUKEMIA BLASTS IDENTIFIES A GROUP OF PATIENTS WITH POOR RESPONSE TO INTENSIVE CHEMOTHERAPY
Authors: WETZLER M BAER MR BERNSTEIN SH BLUMENSON L STEWART C BARCOS M MROZEK K BLOCK AMW HERZIG GP BLOOMFIELD CD
Citation: M. Wetzler et al., EXPRESSION OF C-MPL MESSENGER-RNA, THE RECEPTOR FOR THROMBOPOIETIN, IN ACUTE MYELOID-LEUKEMIA BLASTS IDENTIFIES A GROUP OF PATIENTS WITH POOR RESPONSE TO INTENSIVE CHEMOTHERAPY, Journal of clinical oncology, 15(6), 1997, pp. 2262-2268
INTRODUCTION - ACUTE-LEUKEMIA - RECENT ADVANCES
Authors: BLOOMFIELD CD HERZIG GP CALIGIURI MA
Citation: Cd. Bloomfield et al., INTRODUCTION - ACUTE-LEUKEMIA - RECENT ADVANCES, Seminars in oncology, 24(1), 1997, pp. 1-2
TRANSPLANTATION-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC-UREMIC SYNDROME
Authors: SCHRIBER JR HERZIG GP
Citation: Jr. Schriber et Gp. Herzig, TRANSPLANTATION-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC-UREMIC SYNDROME, Seminars in hematology, 34(2), 1997, pp. 126-133
LONG-TERM SURVIVAL OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA - UPDATED RESULTS FROM 2 TRIALS EVALUATING POSTINDUCTION CHEMOTHERAPY
Authors: BLOOMFIELD CD HERZIG GP PETERSON BA WOLFF SN
Citation: Cd. Bloomfield et al., LONG-TERM SURVIVAL OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA - UPDATED RESULTS FROM 2 TRIALS EVALUATING POSTINDUCTION CHEMOTHERAPY, Cancer, 80(11), 1997, pp. 2186-2190
A RANDOMIZED PHASE-II STUDY OF BB-10010 - A VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA FOR PATIENTS RECEIVING HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR MALIGNANT-LYMPHOMA AND BREAST-CANCER
Authors: BERNSTEIN SH EAVES CJ HERZIG R FAY J LYNCH J PHILLIPS GL CHRISTIANSEN N REECE D ERICSON S STEPHAN M KOVALSKY M HAWKINS K RASMUSSEN H DEVOS A HERZIG GP
Citation: Sh. Bernstein et al., A RANDOMIZED PHASE-II STUDY OF BB-10010 - A VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA FOR PATIENTS RECEIVING HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR MALIGNANT-LYMPHOMA AND BREAST-CANCER, British Journal of Haematology, 99(4), 1997, pp. 888-895
A RANDOMIZED PHASE-II STUDY OF BB-10010 - A VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA) FOR PATIENTS RECEIVING HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR MALIGNANT-LYMPHOMA AND BREAST-CANCER
Authors: BERNSTEIN SH EAVES CJ HERZIG R FAY J LYNCH J PHILLIPS GL CHRISTIANSEN N REECE D ERICSON S STEPHAN M KOVALSKY M HAWKINS K RASMUSSEN H DEVOS A HERZIG GP
Citation: Sh. Bernstein et al., A RANDOMIZED PHASE-II STUDY OF BB-10010 - A VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA) FOR PATIENTS RECEIVING HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR MALIGNANT-LYMPHOMA AND BREAST-CANCER, Blood, 90(10), 1997, pp. 3543-3543
HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITHALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RESISTANT ACUTE MYELOID-LEUKEMIA - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP
Authors: BROWN RA WOLFF SN FAY JW PINEIRO L COLLINS RH LYNCH JP STEVENS D GREER J HERZIG RH HERZIG GP
Citation: Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITHALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RESISTANT ACUTE MYELOID-LEUKEMIA - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP, Leukemia & lymphoma, 22(3-4), 1996, pp. 271-277
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) PRIMING OF HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE - A PILOT TRIAL
Authors: BERNSTEIN SH CHRISTIANSEN NP FAY JP BROWN R HERZIG R FRANKEL S BLUMENSON L HERZIG GP
Citation: Sh. Bernstein et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) PRIMING OF HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE - A PILOT TRIAL, Experimental hematology, 24(12), 1996, pp. 1363-1368
CD34 PROGENITOR-CELL SUBSET ANALYSES IN NORMAL HUMAN BONE-MARROW AND MARROW HARVESTED AFTER INTERMEDIATE-DOSE CHEMOTHERAPY
Authors: LAUGHLIN MJ CHRISTIANSEN NP HERZIG GP BLUMENSON L BONNEY D STEWART CC
Citation: Mj. Laughlin et al., CD34 PROGENITOR-CELL SUBSET ANALYSES IN NORMAL HUMAN BONE-MARROW AND MARROW HARVESTED AFTER INTERMEDIATE-DOSE CHEMOTHERAPY, Cytometry, 26(4), 1996, pp. 235-242
DOSE-INTENSIVE CHEMOTHERAPY WITH ETOPOSIDE-CYCLOPHOSPHAMIDE FOR ADVANCED BREAST-CANCER
Authors: HERZIG RH LYNCH J CHRISTIANSEN NP FAY JW DAVIS MP HERZIG GP
Citation: Rh. Herzig et al., DOSE-INTENSIVE CHEMOTHERAPY WITH ETOPOSIDE-CYCLOPHOSPHAMIDE FOR ADVANCED BREAST-CANCER, Seminars in oncology, 23(2), 1996, pp. 28-32
PARTIAL TANDEM DUPLICATION OF ALL1 AS A RECURRENT MOLECULAR DEFECT INACUTE MYELOID-LEUKEMIA WITH TRISOMY-11
Authors: CALIGIURI MA STROUT MP SCHICHMAN SA MROZEK K ARTHUR DC HERZIG GP BAER MR SCHIFFER CA HEINONEN K KNUUTILA S NOUSIAINEN T RUUTU T BLOCK AW SCHULMAN P PEDERSENBJERGAARD J CROCE CM BLOOMFIELD CD
Citation: Ma. Caligiuri et al., PARTIAL TANDEM DUPLICATION OF ALL1 AS A RECURRENT MOLECULAR DEFECT INACUTE MYELOID-LEUKEMIA WITH TRISOMY-11, Cancer research, 56(6), 1996, pp. 1418-1425
PERSISTENCE OF THE AML1 ETO FUSION TRANSCRIPT IN PATIENTS TREATED WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR T(8-21) LEUKEMIA/
Authors: JURLANDER J CALIGIURI MA RUUTU T BAER MR STROUT MP OBERKIRCHER AR HOFFMANN L BALL ED FREILAHR DA CHRISTIANSEN NP BLOCK AW KNUUTILA S HERZIG GP BLOOMFIELD CD
Citation: J. Jurlander et al., PERSISTENCE OF THE AML1 ETO FUSION TRANSCRIPT IN PATIENTS TREATED WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR T(8-21) LEUKEMIA/, Blood, 88(6), 1996, pp. 2183-2191
MURINE MONOCLONAL-ANTIBODY DIRECTED AGAINST CD3 (OKT3) IS AN EFFECTIVE TREATMENT FOR MODERATE (GRADE-II) BUT NOT FOR SEVERE (GRADE-III OR GRADE-IV) STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD)
Authors: SCHRIBER JR BAER MR CHRISTIANSEN NP MCCARTHY PL SLACK JL TEZCAN H WETZLER M HERZIG GP
Citation: Jr. Schriber et al., MURINE MONOCLONAL-ANTIBODY DIRECTED AGAINST CD3 (OKT3) IS AN EFFECTIVE TREATMENT FOR MODERATE (GRADE-II) BUT NOT FOR SEVERE (GRADE-III OR GRADE-IV) STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 88(10), 1996, pp. 3786-3786
EFFICACY OF HEMODIALYSIS (HD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: SCHRIBER JR MOOKERJEE BK BAER MR CHRISTIANSEN NP MCCARTHY PL SLACK JL TEZCAN H WETZLER M HERZIG GP
Citation: Jr. Schriber et al., EFFICACY OF HEMODIALYSIS (HD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 460-460
A RANDOMIZED PHASE-II TRIAL COMPARING HEPARIN (HEP)+ -PROSTAGLANDIN-E1 (PG) TO PREVENT HEPATOTOXICTY (HT) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) - PRELIMINARY-RESULTS/
Authors: SCHRIBER JR MILK BJ BAER MR CHRISTIANSEN NP MCCARTHY PL SLACK JL TEZCAN H WETZLER M HERZIG GP
Citation: Jr. Schriber et al., A RANDOMIZED PHASE-II TRIAL COMPARING HEPARIN (HEP)+ -PROSTAGLANDIN-E1 (PG) TO PREVENT HEPATOTOXICTY (HT) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) - PRELIMINARY-RESULTS/, Blood, 88(10), 1996, pp. 1642-1642
EXPRESSION OF MESSENGER-RNA ENCODING C-MPL, THE RECEPTOR FOR THROMBOPOIETIN, IN ACUTE MYELOID-LEUKEMIA (AML) BLASTS IDENTIFIES A GROUP OF PATIENTS (PTS) WITH POOR OUTCOME TO INTENSIVE CHEMOTHERAPY
Authors: WETZLER M BAER MR BERNSTEIN SH BLUMENSON L STEWART C BARCOS M MROZEK K BLOCK AMW HERZIG GP BLOOMFIELD CD
Citation: M. Wetzler et al., EXPRESSION OF MESSENGER-RNA ENCODING C-MPL, THE RECEPTOR FOR THROMBOPOIETIN, IN ACUTE MYELOID-LEUKEMIA (AML) BLASTS IDENTIFIES A GROUP OF PATIENTS (PTS) WITH POOR OUTCOME TO INTENSIVE CHEMOTHERAPY, Blood, 88(10), 1996, pp. 2526-2526
BIOLOGICAL EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH UNTREATED ACUTE MYELOID-LEUKEMIA
Authors: BAER MR BERNSTEIN SH BRUNETTO VL HEINONEN K MROZEK K SWANN VL MINDERMAN H BLOCK AW PIXLEY LA CHRISTIANSEN NP FAY JW BARCOS M RUSTUM Y HERZIG GP BLOOMFIELD CD
Citation: Mr. Baer et al., BIOLOGICAL EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH UNTREATED ACUTE MYELOID-LEUKEMIA, Blood, 87(4), 1996, pp. 1484-1494
DESCRIPTION OF AN EFFICIENT AND HIGHLY INFORMATIVE METHOD FOR THE EVALUATION OF HEMATOPOIETIC CHIMERISM FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: OBERKIRCHER AR STROUT MP HERZIG GP FRITZ PD CALIGIURI MA
Citation: Ar. Oberkircher et al., DESCRIPTION OF AN EFFICIENT AND HIGHLY INFORMATIVE METHOD FOR THE EVALUATION OF HEMATOPOIETIC CHIMERISM FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 16(5), 1995, pp. 695-702
Risultati: 1-25 | 26-48